SYROS PHARMACEUTICALS INC (SYRS)
US87184Q2066 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -164.57M | -94.65M | -86.56M | -84.04M | -75.44M | |||
| Depreciation Amortization | 2.25M | 2.97M | 3.02M | 3.04M | 2.72M | |||
| Change In Working Capital | 5.05M | -5.52M | -10.60M | 12.09M | 3.75M | |||
| Interest Paid | 4.55M | 3.41M | 3.19M | 1.51M | 70.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 10.00K | 30.00K | |||
| Other non cash items | 47.56M | -25.86M | -5.40M | 11.55M | 8.71M | |||
| OPERATING CASH FLOW | -109.71M | -123.07M | -99.54M | -57.36M | -60.25M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -272.00K | -1.24M | -1.25M | -3.34M | -12.64M | |||
| Other Investing Activity | 37.61M | 68.43M | -51.41M | 50.00M | 900.00K | |||
| INVESTING CASH FLOW | 37.34M | 67.19M | -52.65M | 46.66M | -11.73M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -65.00K | -590.00K | -270.00K | 39.38M | -210.00K | |||
| Stock Issued/Repurchased | 43.53M | 119.98M | 70.82M | 103.78M | 66.20M | |||
| Other Financing Activity | 0.00 | 11.66M | -40.00K | -210.00K | N/A | |||
| FINANCING CASH FLOW | 43.46M | 131.05M | 70.51M | 142.95M | 65.99M | |||
| CHANGE IN CASH | -28.91M | 75.17M | -81.68M | 132.25M | -5.99M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -109.71M | -123.07M | -99.54M | -57.36M | -60.25M | |||
| Capital Expenditure | -272.00K | -1.24M | -1.25M | -3.34M | -12.64M | |||
| FREE CASH FLOW | -109.98M | -124.31M | -100.79M | -60.70M | -72.89M | |||
All data in USD